The area under the tongue has a dense network of blood vessels, making it one of the most permeable mucous membranes in the body
While compounded medications are produced in licensed facilities and regulated by state Boards of Pharmacy, they have not been evaluated by the FDA for safety, quality, or efficacy
Some will be looking for medication only
The Society welcomes NICEs endorsement of lebrikizumab as an additional treatment option for eligible individuals with moderate to severe atopic eczema, emphasizing the importance of providing diverse treatment choices to match patients needs. Jorgen Damsbo, General Manager at Almirall, UK, remarked, The NICE recommendation for lebrikizumab reflects its proven effectiveness with 4-weekly maintenance dosing and a favorable safety profile, aligning with our commitment to improving patients lives by helping them achieve better health. Professor Tony Bewley, Consultant Dermatologist at Barts Health NHS Trust and Honorary Professor of Dermatology at QMUL, emphasized the significant psychosocial burden of atopic dermatitis, noting that lebrikizumabs approval marks a crucial advancement that is welcomed by both patients and clinicians
